MedPath

PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine

Completed
Conditions
Migraine
Interventions
Device: Polysomnography
Registration Number
NCT04413110
Lead Sponsor
Mansoura University Hospital
Brief Summary

Transformed migraine is the most common and challenging subtype of chronic daily headache disorders35. Patients with transformed migraine often report an evolutionary process that occurs over months or years in which headaches increase in frequency, change characteristics and ultimately result in patterns of daily or near-daily headaches resembling a mixture of tension-type headache and migraine.

Detailed Description

The present study aimed to investigate the presence and frequency of cognitive affection in patients with transformed migraines, as well as to analyze the association of cognitive affection with clinical features and headache impact, anxiety, depression, and quality of sleep.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
161
Inclusion Criteria

-Patients included were adults with clinically confirmed of chronic migraine

Exclusion Criteria
  • Primary headache disorder other than migraine
  • Secondary headache disorders other than medication-overuse headache or unclassified headache, or
  • Aged under 18 years or older than 65 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control groupPolysomnographyAge and sex matched healthy controls
Subjective cognitive impairedPolysomnographyCases of migraine and subjective cognitive impaired
Primary Outcome Measures
NameTimeMethod
Polysomnography24-72 hours

PSG was carried out for 41 patients with subjective cognitive impairment and 41 age and sex-matched controls. PSG with standard EEG montage that includes bilateral EOG and four EEG leads were used. A single attended overnight PSG study was performed at the Clinical Neurophysiology Unit of Mansoura University Hospitals. Patients were studied in a quiet, darkened room with no medications were used to induce sleep. All participants underwent one night of laboratory-based PSG.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mansoura University Hospital

🇪🇬

Mansoura, Dakahlia, Egypt

© Copyright 2025. All Rights Reserved by MedPath